823
Participants
Start Date
July 5, 2019
Primary Completion Date
July 31, 2023
Study Completion Date
October 31, 2023
Busulfan
Busulfan（4 mg/kg/day,4 days）
Cyclophosphamide
Cyclophosphamide（50 mg/kg/day,4 days）
Fludarabine
Fludarabine（50 mg/m2/day,3 days）
Thymoglobulin
Thymoglobulin（2.5 mg/kg/day,4 days）
cyclosporine A
cyclosporine A
Mycophenolate mofetil
Mycophenolate mofetil（0.25g/day）
Tacrolimus
Tacrolimus
Methotrexate
Methotrexate
First Affiliated Hospital of Guangxi Medical University, Nanning
Collaborators (1)
Peking University People's Hospital
OTHER
Ruijin Hospital
OTHER
The 923rd Hospital of Joint Logistics Support Force of People's Liberation Army
OTHER
LiuZhou People's Hospital
OTHER
The First People's Hospital of Yunnan
OTHER
Liuzhou Workers' Hospital
OTHER_GOV
Xinqiao Hospital of Chongqing
OTHER
Affiliated Hospital of Youjiang University of Ethnic Medicine
UNKNOWN
Hainan People's Hospital
OTHER
Maoming People's Hospital
OTHER
Red Cross Hospital of Yulin City
OTHER
Guilin Medical College
OTHER
Wuzhou People's Hospital
UNKNOWN
Guangxi Autonomous Region People's Hospital
UNKNOWN
The 920th Hospital of Joint Logistics Support Force of People's Liberation Army
UNKNOWN
First Affiliated Hospital of Guangxi Medical University
OTHER